Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring MRD in Patients With Chronic Lymphocytic Leukemia

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing